SERUM VEGF AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN HODGKIN LYMPHOMA

M. Weyl Ben Arush, A. Ben Barak, Sarah Maurice, E. Livne

Pediatric Hematology and Oncology · 2007 · 15 citations · 15 references

Concepts

Abstract

This pilot study aimed at determining serum VEGF levels (S-VEGF) at diagnosis and at restaging in children with Hodgkin lymphoma, and investigating whether this parameter provides prognostic information for remission after 2 courses of chemotherapy. PET-CT fusion was performed to assess response to treatment. Changes in S-VEGF levels were found to correlate with response to treatment for most of the children. This provides a rationale for exploring clinical interest in S-VEGF measurements in a larger group of children with Hodgkin lymphoma, and using the test for clinical trials of anti-angiogenic therapies.

References

15